Internal Medicine · Memphis, TN
NPI
1962453225
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1264 Wesley Dr, Suite 501
Memphis, TN, 38116
Phone (901) 346-1800
Groups this clinician bills Medicare through
Medicare paid, 2024
$112K
6,113 services
Medicare patients, 2024
112
Average age 76
Drug cost, 2024
$1.3M
13,267 prescriptions
Company payments, 2025
$267
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ahsan H Kathawala was code J1010 (injection, methylprednisolone acetate, 1 mg), 2,000 times for 16 patients. In total Ahsan H Kathawala billed 6,113 services in 83 codes, and Medicare paid $112K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,000 | 16 | $0.10 | $198 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 492 | 24 | $0.08 | $41.26 |
| 82947 Clinical Chemistry | Office | 313 | 96 | $3.85 | $1,205 |
| 99214 Office E&M - Established | Office | 280 | 96 | $79.66 | $22K |
| 96372 Injection Administration | Office | 243 | 64 | $9.71 | $2,360 |
| 99213 Office E&M - Established | Office | 221 | 94 | $53.16 | $12K |
| 85025 Blood Count | Office | 161 | 74 | $7.61 | $1,225 |
| 73560 X-ray - Lower Extremity | Office | 151 | 75 | $21.70 | $3,277 |
| 93000 Electrocardiogram | Office | 148 | 92 | $9.51 | $1,407 |
| 36415 Venipuncture Blood Collection | Office | 124 | 90 | $8.65 | $1,073 |
| J1885 Injection, ketorolac tromethamine, per 15 mg | Office | 120 | 16 | $0.48 | $57.21 |
| J0696 Injection, ceftriaxone sodium, per 250 mg | Office | 112 | 20 | $0.35 | $39.25 |
| 94375 Pulmonary Function Testing | Office | 107 | 87 | $25.81 | $2,762 |
| 71046 X-ray - Chest | Office | 88 | 80 | $19.87 | $1,748 |
| 81003 Clinical Chemistry | Office | 81 | 68 | $2.20 | $178 |
By year: 2022 $124K for 4,407 services; 2023 $113K for 4,139 services; 2024 $112K for 6,113 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 313 | 96 | $3.85 | $1,205 |
| 85025 Blood Count | 161 | 74 | $7.61 | $1,225 |
| 36415 Venipuncture Blood Collection | 124 | 90 | $8.65 | $1,073 |
| 81003 Clinical Chemistry | 81 | 68 | $2.20 | $178 |
| 82270 Immunoassay | 51 | 51 | $4.29 | $219 |
| 87804 Immunoassay | 36 | 14 | $16.22 | $584 |
| 87426 Immunoassay | 19 | 14 | $34.62 | $658 |
Medicare prescription drug claims, 2024
In 2024, the drug Ahsan H Kathawala prescribed most often to Medicare patients was Atorvastatin Calcium, with 803 prescriptions and refills. In total Ahsan H Kathawala wrote 13,267 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 803 | 2,309 | 268 | $8,451 |
| Amlodipine Besylate Generic | 632 | 1,814 | 226 | $3,712 |
| Rosuvastatin Calcium Generic | 586 | 1,695 | 202 | $9,566 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 438 | 1,238 | 143 | $7,653 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 348 | 426 | 119 | $9,825 |
| Omeprazole Generic | 310 | 860 | 108 | $4,968 |
| Clonidine Hcl Generic | 297 | 795 | 108 | $3,750 |
| Furosemide Generic | 276 | 662 | 106 | $1,233 |
| Pantoprazole Sodium Generic | 264 | 744 | 108 | $2,896 |
| Carvedilol Generic | 255 | 752 | 93 | $2,289 |
| Metoprolol Succinate Generic | 224 | 628 | 84 | $2,394 |
| Tamsulosin Hcl Generic | 224 | 643 | 74 | $2,953 |
| Potassium Chloride Generic | 223 | 606 | 89 | $3,764 |
| Meloxicam Generic | 203 | 457 | 84 | $845 |
| Olmesartan-Amlodipine-Hctz Olmesartan/Amlodipin/Hcthiazid | 201 | 502 | 68 | $31K |
Brand drugs: 1,381 claims; generic drugs: 11,777 claims; opioid claims: 236.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ahsan H Kathawala $267 ($267 in general payments such as food, travel and fees) from 3 companies. The largest payer was Novo Nordisk Inc with $136.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.